Controversy on efficacy of Ursa is meaningless: Daewoong

Published: 2013-10-07 06:56:00

Updated: 2013-10-07 06:56:00

The Press Arbitration Commission (PAC) has recently called for a local media to delete its articles on the efficacy of Ursa, the best-selling hepatic function medicine, in a bid to end disputes caused by the media’s report, Daewoong Pharm said Wednesday.

The media reported on Sept. 11 and 12 t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK